Product Information

DOXEPIN HCL 3 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $1.3184 per EA under NDC 64380020301. Its NADAC has been published 208 times since Nov 30, 2022.

FDA first approved this application on Jul 24, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXEPIN HCL 3 MG TABLET

doxepin hydrochloride
$1.3184per EA

Strength

3 mg/1

NDC

64380020301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DOXEPIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202510

FDA Approved

7/24/2020

TE Code

AB

On Market Since

9/12/2022

Pharmacological Classes

Price Statistics

The NADAC for DOXEPIN HCL 3 MG TABLET has been published 208 times since Nov 30, 2022, and over the history we have for it it has declined 82.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3184 per EA
All-time high$8.1473 (Sep 13, 2023)
All-time low$1.3184 (Nov 18, 2026)
52-week high$2.0842
52-week low$1.3184
Median price$2.8046
Average price$3.8147
Largest weekly change-32.6% (Sep 20, 2023)
Weeks tracked208
Tracking sinceNov 30, 2022

Price History

1W

-3.4%

1M

-1.1%

3M

-3.4%

6M

-12.6%

1Y

-36.7%

3Y

-73.1%

5Y

N/A

All

-82.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXEPIN HCL 3 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN HCL 3 MG TABLET, manufactured by Strides Pharma Inc., is $1.3184 per EA (NDC 64380020301), effective Nov 18, 2026.

How has the price of DOXEPIN HCL 3 MG TABLET changed over time?

Over the history we have for it, the NADAC for DOXEPIN HCL 3 MG TABLET has declined 82.9%. It has been tracked across 208 weekly CMS publications since Nov 30, 2022.

What are the highest and lowest recorded NADAC prices for DOXEPIN HCL 3 MG TABLET?

Since Nov 30, 2022, the NADAC for DOXEPIN HCL 3 MG TABLET has ranged from a low of $1.3184 (Nov 18, 2026) to a high of $8.1473 (Sep 13, 2023), with a median of $2.8046 per EA.

Are there cheaper alternatives to DOXEPIN HCL 3 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXEPIN HCL 3 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DOXEPIN HCL 3 MG TABLET?

DOXEPIN HCL 3 MG TABLET (NDC 64380020301) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.